Showing results (201-210 of 276) with videos related to

Sort By:
Pageof 28
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1983
Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brainA Reches, R E Burke, C M Kuhn, et al.
Annals of Neurology|November 18, 2000
A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathyD Thyagarajan, S Bressman, C Bruno, et al.
Plos One|July 17, 2010
Gene expression analysis of forskolin treated basilar papillae identifies microRNA181a as a mediator of proliferationCorey S Frucht, Mohamed Uduman, Jamie L Duke, et al.
Neurology|January 14, 2004
Evaluation of the pull test technique in assessing postural instability in Parkinson's diseaseR P Munhoz, J-Y Li, M Kurtinecz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1995
Dystonia in a patient with deletion of 18qM F Gordon, S Bressman, M F Brin, et al.
Neurology|December 1, 1982
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugsR E Burke, S Fahn, J Jankovic, et al.
Neurology|October 1, 1990
Dopamine beta-hydroxylase activity in cerebrospinal fluid of idiopathic torsion dystoniaD H Park, U J Kang, C B Moskowitz, et al.
Neurology|September 1, 1979
Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapyR P Lesser, S Fahn, S R Snider, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Teaching tape for the motor section of the unified Parkinson's disease rating scaleC G Goetz, G T Stebbins, T A Chmura, et al.
Neurology|October 22, 1998
A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study GroupA Lieberman, C W Olanow, K Sethi, et al.
Pageof 28